Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Merck
Accenture
Baxter
Harvard Business School
Chinese Patent Office
Cerilliant
Daiichi Sankyo
Boehringer Ingelheim

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,617,593

« Back to Dashboard

Which drugs does patent 8,617,593 protect, and when does it expire?

Patent 8,617,593 protects VASCEPA and is included in one NDA.

This patent has twenty-four patent family members in twenty-one countries.
Summary for Patent: 8,617,593
Title:Stable pharmaceutical composition and methods of using same
Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
Inventor(s): Manku; Mehar (England, GB), Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:13/768,869
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 8,617,593

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF REDUCING TG LEVELS IN PATIENT ON STATIN THERAPY SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA ➤ Try a Free Trial
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,617,593

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,060,982 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
9,585,856 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,298,554 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,454,994 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,623,406 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,709,475 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,501,225 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,613,945 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,642,077 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
8,617,594 Stable pharmaceutical composition and methods of using same ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,617,593

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 2424356 ➤ Try a Free Trial
Singapore 10201605794P ➤ Try a Free Trial
Singapore 175389 ➤ Try a Free Trial
Russian Federation 2014131716 ➤ Try a Free Trial
Russian Federation 2538691 ➤ Try a Free Trial
Russian Federation 2011148362 ➤ Try a Free Trial
Portugal 2424356 ➤ Try a Free Trial
New Zealand 627238 ➤ Try a Free Trial
New Zealand 595852 ➤ Try a Free Trial
Malaysia 157120 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
US Army
Mallinckrodt
Cipla
Chinese Patent Office
Deloitte
Covington
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot